STK4 INHIBITORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES
The application relates to compounds of Formula (I'): which modulate the activity of a kinase (e.g., STK4), a pharmaceutical composition comprising the compound, and a method of treating or preventing a disease or disorder associated with the modulation of a kinase, such as STK4.
-
Paragraph 00787
(2017/01/09)
Novel Bicyclic Pyridinones
Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
-
Page/Page column 23
(2012/10/08)
More Articles about upstream products of 1402003-93-3